A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
Weight gain is common in women going through menopause. It can be caused by a variety of factors, including hormone ...
In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...